| | | 54571 | | 28.09.1999 | | Novo Nordisk Pharma AG | | 27.09.2004 | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | NovoNorm 0,5 mg | Tabletten | Tabletten (Repaglinidum 0.5 mg) | A10BX02 | PI | | 02 | NovoNorm 1,0 mg | Tabletten | Tabletten (Repaglinidum 1 mg) | A10BX02 | PI | | 03 | NovoNorm 2,0 mg | Tabletten | Tabletten (Repaglinidum 2 mg) | A10BX02 | PI |
|
|
